Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Ave, Boston, MA 02115, USA.
Environ Health. 2013 Sep 13;12(1):80. doi: 10.1186/1476-069X-12-80.
Associations of bisphenol A and phthalates with chronic disease health outcomes are increasingly being investigated in epidemiologic studies. The majority of previous studies of within-person variability in urinary bisphenol A and phthalate metabolite concentrations have focused on reproducibility over short time periods. Long-term reproducibility data are needed to assess the potential usefulness of these biomarkers for prospective studies, particularly those examining risk of diseases with long latency periods. Low within-person reproducibility may attenuate relative risk estimates and reduce statistical power to detect associations with disease. Therefore, we assessed within-person reproducibility of bisphenol A, eight phthalate metabolites, and phthalic acid in spot urine samples over 1 to 3 years among women enrolled in two large cohort studies.
Women in the Nurses' Health Study and Nurses' Health Study II provided two spot urine samples, 1 to 3 years apart (n = 80 women for analyses of bisphenol A; n = 40 women for analyses of phthalate metabolites; n = 34 women for analyses of phthalic acid). To measure within-person reproducibility, we calculated Spearman rank correlation coefficients and intraclass correlation coefficients for creatinine-adjusted concentrations of bisphenol A, phthalate metabolites, and phthalic acid.
Over 1 to 3 years, within-person variability of bisphenol A was high relative to total variability (intraclass correlation coefficient = 0.14) and rankings of bisphenol A levels between time-points were weakly correlated (Spearman correlation = 0.19). Seven of the eight phthalate metabolites and phthalic acid demonstrated moderate within-person stability over time (Spearman correlation or intraclass correlation coefficient = 0.39-0.55). Restricting analyses to first-morning urine samples did not alter results.
Single measurements of bisphenol A in spot urine samples were highly variable within women over 1 to 3 years, indicating that investigation of associations between a single urinary bisphenol A measurement and disease risk may be challenging in epidemiologic studies. The majority of urinary phthalate metabolites and phthalic acid appeared moderately reproducible within women over time, suggesting single measurements may be useful in epidemiologic studies, although observed relative risks can be substantially attenuated.
双酚 A 和邻苯二甲酸酯与慢性病健康结果的关联在越来越多的流行病学研究中得到了研究。先前大多数关于尿液中双酚 A 和邻苯二甲酸酯代谢物浓度个体内变异性的研究都集中在短时间内的可重复性上。需要长期的可重复性数据来评估这些生物标志物在前瞻性研究中的潜在用途,特别是那些研究具有长潜伏期疾病风险的研究。个体内可重复性低可能会降低相对风险估计值,并降低检测疾病关联的统计能力。因此,我们评估了在两项大型队列研究中,女性在 1 至 3 年内的两个尿液样本中双酚 A、8 种邻苯二甲酸酯代谢物和邻苯二甲酸的个体内可重复性。
护士健康研究和护士健康研究 II 的女性提供了两次尿液样本,相隔 1 至 3 年(分析双酚 A 的 80 名女性;分析邻苯二甲酸酯代谢物的 40 名女性;分析邻苯二甲酸的 34 名女性)。为了测量个体内的可重复性,我们计算了双酚 A、邻苯二甲酸酯代谢物和邻苯二甲酸的肌酐调整浓度的斯皮尔曼等级相关系数和组内相关系数。
在 1 至 3 年内,双酚 A 的个体内变异性相对于总变异性较高(组内相关系数为 0.14),且两个时间点之间的双酚 A 水平排名相关性较弱(Spearman 相关系数为 0.19)。8 种邻苯二甲酸酯代谢物和邻苯二甲酸中的 7 种在时间上表现出中等程度的个体内稳定性(Spearman 相关系数或组内相关系数为 0.39-0.55)。将分析限制在第一次晨尿样本中并没有改变结果。
在 1 至 3 年内,女性单次尿液样本中的双酚 A 高度可变,表明在流行病学研究中,单次尿液双酚 A 测量与疾病风险之间的关联可能具有挑战性。大多数尿液邻苯二甲酸酯代谢物和邻苯二甲酸在女性体内随时间具有中等程度的可重复性,表明单次测量可能在流行病学研究中有用,尽管观察到的相对风险可能会大大降低。